HIF1A and hepatocellular carcinoma: Currently, only one study has reported the anti-hepatocellular carcinoma effect of inotodiol, which demonstrated that inotodiol is capable of markedly suppressing the growth of HCC cells, and the target of its action was HIF-1α [10].